Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 4 | |
Sell | 2 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Pacira Biosciences Inc have a median target of 18.50, with a high estimate of 56.00 and a low estimate of 8.00. The median estimate represents a 6.44% increase from the last price of 17.38.
High | 222.2% | 56.00 |
Med | 6.4% | 18.50 |
Low | -54.0% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | +6.40% |
Average growth rate | +15.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1.00% |
Average growth rate | +13.11% |
More ▼